• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta and Mathematica partner to advance public health and health equity with real-world data

Truveta and Mathematica partner to advance public health and health equity with real-world data

by Truveta staff | Sep 21, 2023 | News

Truveta, a leading EHR data and analytics company, and Mathematica, a policy research and data analytics consultancy, today announced a partnership to advance medical research in the areas of public health surveillance, health equity, and maternal health. By engaging...
Truveta collaboration with Harvard University researchers published in JAMA Network Open

Truveta collaboration with Harvard University researchers published in JAMA Network Open

by Truveta Research | May 11, 2023 | News, Research

Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena, MD, PhD and Christopher M Worsham, MD, MPH from Harvard University, the new research...
How better medical device data can create better patient outcomes

How better medical device data can create better patient outcomes

by Truveta staff | May 5, 2023 | Technology

Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in clinical practice and the related outcomes. Understanding clinical outcomes or adverse events...
ISPOR 2023: Presenting Truveta Research’s recent type 2 diabetes findings

ISPOR 2023: Presenting Truveta Research’s recent type 2 diabetes findings

by Truveta staff | May 4, 2023 | News

This post is authored by Tricia Rodriguez, senior applied scientist, Truveta Research. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is gearing up for a fantastic event, slated for May 7-10, 2023, in Boston. As an applied scientist with...
How does approval of a new Alzheimer’s drug impact genetic testing?

How does approval of a new Alzheimer’s drug impact genetic testing?

by Truveta Research | Apr 21, 2023 | Research, Research Insights

The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having the disease (National Institute on Aging, 2021). It is currently ranked as the seventh...
« Older Entries
Next Entries »

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice